An Phase I Study of YY001 in Patients with Advanced Solid Tumors

NCT06228846 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: YY001

Sponsor

Shanghai Yuyao Biotech Co., Ltd.